Exploring the Role of Interleukin-6 Receptor Inhibitor Tocilizumab in Patients with Active Rheumatoid Arthritis and Periodontal Disease

Background: The aim of our study was to explore the influence of weekly subcutaneous administration of interleukin-6 (IL-6) receptor inhibitor tocilizumab (TCZ) on periodontal status in a local longitudinal study of patients with rheumatoid arthritis (RA) and periodontal disease (PD). Methods: We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ancuța, Codrina, Chirieac, Rodica, Ancuța, Eugen, Țănculescu, Oana, Solomon, Sorina Mihaela, Fătu, Ana Maria, Doloca, Adrian, Iordache, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924637/
https://www.ncbi.nlm.nih.gov/pubmed/33672771
http://dx.doi.org/10.3390/jcm10040878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924637/
https://www.ncbi.nlm.nih.gov/pubmed/33672771
http://dx.doi.org/10.3390/jcm10040878

Ejemplares similares